Evidence map›Paper›PMID 40979141›Full record

ReviewNuclear medicine and molecular imaging2025

Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Batool Albalooshi, Maryam Alkuwari, Dyab Al Mahariq, Khalsa Al-Nabhani, Abdullah Alqarni, Mohammed Al-Rowaily, Riyadh AlSalloum, Murat Fani Bozkurt and 8 more

Erratum issuedAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Nuclear Medicine in IRAQ: From a Pioneering Past to Future Progress.Journal of multidisciplinary healthcare · 2026
    Review
  2. Review
  3. Bridging the Gap in Theranostics: Where Do We Stand?Nuclear medicine and molecular imaging · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Queen Rania Street Al Jubeiha, Amman, 11941 Jordan.ORCID 0000-0002-0978-4716
Ahmed Saad AbdlkadirDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Queen Rania Street Al Jubeiha, Amman, 11941 Jordan.
Batool AlbalooshiDubai Nuclear Medicine and Molecular imaging Center, Dubai Health Authority, Dubai, UAE.
Maryam AlkuwariDepartment of Cardiology Cardiac Imaging, Hamad Medical Corporation, Doha, Qatar.
Dyab Al MahariqDepartment of Radiology, Augusta Victoria Hospital, Jerusalem, Palestine.
Khalsa Al-NabhaniDepartment of Nuclear Medicine and Molecular Imaging, Royal Hospital, Muscat, Oman.
Abdullah AlqarniNuclear Medicine Department, Prince Sultan Medical Military City, Riyadh, Saudi Arabia.
Mohammed Al-RowailyDepartment of Radiology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Riyadh AlSalloumDepartment of Radiology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Murat Fani BozkurtFaculty of Medicine, Department of Nuclear Medicine, Hacettepe University, Ankara, Turkey.
Habibollah DadgarDepartment of Nuclear Medicine and Molecular imaging, Cancer Research Center, RAZAVI Hospital, Mashhad University of Medical Science, Mashhad, Iran.
Abdulredha EsmailJaber Al-Ahmad Molecular Imaging Center, Kuwait City, Kuwait.
Shazia FatimaDepartment of Nuclear Medicine, Nuclear Medicine, Oncology and Radiotherapy Institute (NORI), Islamabad, Pakistan.
Mohamad HaidarNuclear Medicine Division, Department of Diagnostic Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Aysar KhalafDepartment of Nuclear Medicine, Warith International Cancer Institute, Karbala, 56001 Iraq.
Fairoz MohammedDepartment of Nuclear Medicine and Radiation Oncology, Althawra hospital, Sanaa, Yemen.
Fuad NovruzovNuclear Medicine Department, National Centre of Oncology, Baku, Azerbaijan.
Majdi ZeinNuclear Medicine Division, National University Hospital, Damascus, Syria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This surveillance study examined the status of theranostics in West Asia, analyzing data from 15 countries. The research assessed availability, production, coverage, staff density, infrastructure density, financial and political impacts. All surveyed countries except Yemen offered theranostic services, with 452 centers and 1,426 theranostic physicians across the region. Over half of the countries reported densities exceeding one theranostician, nuclear medicine technologist, physicist, and nurse per million inhabitants. Scientific and social activities were available in nine and ten countries, respectively. Countries with gross domestic product (GDP) below $200 billion showed significantly lower infrastructure and manpower resources, particularly in cyclotron availability and theranostic agents (

Indexed as

ConflictsRadionuclide therapyTheranostic advancesTheranostic challengesTheranosticsWest Asia

Identifiers

PMID40979141
PMCPMC12446171

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.